"送过来！"没有犹豫，肾脏病中心立即启动危重症抢救预案。呼吸机辅助呼吸、抗病毒治疗、连续性血 液净化、多器官功能支持等等，经过两周的持久奋战，肾脏病中心的医护人员为小张坚守了多个日夜， 小张终于初步脱离了危险。 转自：扬子晚报 "是二附院，几次将我的命救回来。"近日，35岁的小张（化名）接受了他人生中的第二次肾移植手术。 从12岁那年初遇，到如今而立之年，跨越23年，他与南京医科大学第二附属医院曾三度生命相托，得以 重新开启人生的篇章。 腹痛昏迷，二附院首度拯救少年 2003年，12岁的小张因反复便血，伴全身多处出血点，其间尿常规提示血尿、蛋白尿均为4+，在当地 多家医院辗转治疗后无明显改善。一个午后，小张出现腹痛进行性加重，突然陷入昏迷，当地医院束手 无策之际，家人抱着最后一线希望将他送到南医大二附院。经过急诊抢救、多学科会诊后，小张被诊断 为过敏性紫癜合并肠穿孔，经过一场惊心动魄的手术以及精心的术后治疗和护理，小张的状态终于有了 好转。随后，小张接受肾穿刺活检，最终病理诊断为紫癜性肾炎，为后续治疗指明了方向。经过儿科专 家甘卫华主任数周的精心救治，小张的病情得以稳定控制。 重症白肺，二附院伴他突围险境 2 ...

（来源：衢州日报） 2022年4月，陈某投资设立某血液透析中心并担任院长。为吸引患者就诊、谋取非法利益，该中心以低 价治疗、发放补贴、免费接送等"福利"为诱饵，重点针对低保户血液透析患者开展营销。 转自：衢州日报 法律依据：本案中，医保基金属于公共财产范畴。被告人以非法占有为目的，利用经营医疗机构的便 利，虚构医疗服务事实，骗取医保基金，其行为完全符合《中华人民共和国刑法》第二百六十六条规定 的诈骗罪的构成要件。法院的判决不仅评价了其诈骗公共财产的罪行，也实质上否定了其通过违法手段 进行不正当竞争、扰乱正常医疗市场与监管秩序的经营模式，维护了市场经济所必需的法治原则与诚信 基石。 通讯员 石洁 王元欣 风险提示：在激烈的市场竞争中，任何市场主体都必须将合规经营放在首位，严禁通过虚构服务、欺诈 欺瞒等违法手段获取竞争优势或非法利润，否则终将受到法律的严厉制裁。 医保基金是人民群众的"看病钱""救命钱"，更是受法律严格保护的公共财产，其安全高效运行直接关系 国计民生与公共服务质量。近日，一起民营医院以"优惠福利"为幌子、虚构诊疗项目骗取医保基金的案 件依法宣判，三名相关责任人均因诈骗罪被判处刑罚，彰显了司法机关守 ...

中新网长治2月9日电 题：为尿毒症患者"生命线"兜底 中新网记者 范丽芳 寒曦初露，山西省长治市沁源县郭道镇尚未完全醒来，王锦虎已收拾妥当，并细心地帮妻子张爱珍拉好 棉衣拉链、扶上轮椅。虽距离做血液透析的医院仅几百米，他仍不愿让患病16年的妻子走路受累。 "现在政策好，透析花钱少；医生护士好，对我们跟亲人一样；作为家属，我每天也在尽力照顾好 她。"王锦虎的言语里，透着历经风雨后的踏实。 着轮椅，送妻子张爱珍做血液透析。苏泽晟 摄 漫漫求医路 2010年，沁源县王和镇的张爱珍被确诊为尿毒症。"当时医生拿着检查报告问我，家里经济条件怎么 样，这病治起来很费钱。"靠打零工维生、儿女尚在读书的王锦虎，瞬间觉得"腿都抬不起来"。 不能放弃。王锦虎让妻子开始了相对省钱的居家腹膜透析。其间，并发症让夫妻俩数次奔波于长治与近 500公里外的西安。绿皮火车一坐十几个小时，手术费、药费、路费……"至少花了30多万元。"王锦虎 回忆。 2022年，因身体状况变化，张爱珍必须转为费用更高的血液透析。正发愁时，他们得知沁源县第二人民 医院可以进行血液透析，而且县财政对透析费用"兜底"。希望，在困境中亮起。 负担减、就近医 尿毒症患者需 ...

Group 1 - Linyi City is the only pilot city in the province for medical service price reform, implementing 18 price adjustments during the 14th Five-Year Plan period [2] - A total of 346 medical service project prices have been adjusted downwards, with a projected reduction of 256 million yuan in patient expenses for 2024 [2] - The price governance has included six batches of price standardization, significantly reducing costs for high-volume and high-price items, such as a 46% reduction in the price of thromboelastography tests [2] Group 2 - The new pricing policy considers the medical needs of special groups, particularly for patients requiring long-term hemodialysis, with significant price reductions implemented [3] - The new tiered pricing for hemodialysis treatment is set at 320, 280, and 240 yuan per session for tertiary, secondary, and primary hospitals respectively, eliminating additional monitoring fees [3] - The policy encourages patients to seek treatment at lower-tier hospitals, resulting in lower fees and higher reimbursement rates, thereby reducing personal financial burdens [3]

Group 1 - The article emphasizes the importance of monitoring and managing health issues in dialysis patients, highlighting ten key organs that require attention [1] - It outlines specific health risks associated with each organ, such as hypertension and heart failure for the heart, and infection and thrombosis for vascular access [1] - The article provides actionable recommendations for each health issue, including dietary adjustments, regular monitoring, and medical interventions [1] Group 2 - Shenzhen Yongfu Hospital is a modern comprehensive hospital approved by the Shenzhen Health and Family Planning Commission, integrating medical services, teaching, research, health care, rehabilitation, emergency services, and community services [3] - The hospital has a planned construction area of over 40,000 square meters and 600 beds, and it is included in the key construction projects of the Shenzhen municipal government's health planning [3] - It is built according to the standards of a tertiary comprehensive hospital and serves as a unit for Shenzhen's medical insurance, maternity insurance, and health check-ups [3]

Core Viewpoint - The article discusses the lives of patients with uremia who find work in specialized factories that cater to their medical needs, highlighting the intersection of health and employment in their struggle for survival [4][6][55]. Group 1: Patient Experiences - Patients like Li Xiaoming, who suffer from uremia, often face a bleak future and seek work to support their medical expenses while dealing with the emotional toll of their condition [5][9]. - The article illustrates how these patients, referred to as "kidney friends," bond over shared experiences and challenges in their daily lives, often working in factories that accommodate their medical needs [6][10]. - The emotional and psychological struggles of patients are emphasized, as many feel isolated and burdened by their conditions, leading to a desire for normalcy through work [19][34]. Group 2: Employment Opportunities - The emergence of specialized factories, such as those run by former medical professionals, provides employment opportunities for uremia patients, allowing them to work while receiving treatment [46][55]. - These factories are designed to be accommodating, offering flexible work hours and a supportive environment, which contrasts with traditional workplaces that often reject patients due to their medical conditions [50][62]. - The article notes that the demand for such employment is driven by the financial struggles of patients, many of whom cannot afford the costs of treatment without a steady income [47][55]. Group 3: Healthcare Policies - The article highlights the impact of healthcare policies on the lives of uremia patients, particularly the improvements in medical insurance that have made treatment more affordable [55][56]. - The establishment of independent dialysis centers and the reduction of treatment costs through insurance reforms have created a more accessible healthcare environment for patients [55][58]. - The increasing number of dialysis centers and the competitive market have led to innovative solutions, such as the "work-for-treatment" model, which integrates employment with medical care [59][60].

Core Points - The Linyi City government announced adjustments to the pricing of six categories of medical services, effective from August 1, 2025, in accordance with provincial regulations [2] - The adjustments include the integration of 118 medical service pricing items such as heart and liver transplants, while abolishing 429 items like corneal transplants and plasma exchange [2] - The pricing for CT scans in tertiary medical institutions has been reduced from 312 yuan per part to 230 yuan per part, resulting in a total cost reduction of approximately 45% for multiple scans [2] Summary of Adjustments - The adjustments aim to standardize and reduce costs for various medical services, particularly focusing on high-cost diagnostic and treatment procedures [2] - Blood dialysis treatment costs have been lowered, with new tiered pricing: 320 yuan per session in tertiary hospitals, 280 yuan in secondary hospitals, and 240 yuan in primary hospitals, eliminating an additional monitoring fee [3] - The new pricing policy encourages patients to seek treatment in lower-tier hospitals, thereby reducing their personal financial burden and increasing reimbursement rates [3]

Core Viewpoint - The conference highlighted the importance of standardized blood perfusion treatment for uremic patients and the impact of new medical insurance policies on combination blood purification therapy [1][9]. Group 1: Significance of Standardized Blood Perfusion Treatment - The number of uremic patients in China exceeds one million, necessitating standardized treatment to improve patient quality of life [4]. - Blood perfusion has evolved from exploratory use to standardized treatment, showing clear clinical benefits when combined with dialysis [4]. - The goal of blood perfusion technology is to extend survival and enhance the quality of life for uremic patients, allowing them to reintegrate into society [4][12]. Group 2: Comprehensive Management Strategies - Improving the quality of life for uremic patients requires a multifaceted management strategy, including medical technology optimization, nutritional support, and psychosocial interventions [5]. - Regular blood dialysis combined with blood perfusion is recommended to effectively manage long-term complications such as calcium-phosphorus metabolism disorders and renal anemia [5][11]. Group 3: Lifestyle Management and Patient Awareness - Daily lifestyle management is crucial for kidney health, with self-management awareness being a key factor in preventing chronic diseases [6][7]. - The rise in uremic patients is linked to unhealthy dietary habits, particularly among younger generations, highlighting the need for early intervention [7]. Group 4: Impact of New Medical Insurance Policies - The new medical insurance policy provides clear guidelines for the charging and promotion of combination blood purification therapy, addressing long-standing issues in clinical practice [10]. - The policy has been implemented in 21 provinces, enhancing the professional value of nursing staff and supporting the standardized application of weekly blood perfusion treatment [10][11]. Group 5: Evidence and Economic Viability of Blood Perfusion - Studies have shown that regular blood perfusion treatment significantly improves the clearance of middle-molecule toxins and enhances patient quality of life [12]. - Blood perfusion is not only effective but also economical, reducing severe complications and overall societal and familial burdens [12][13]. Group 6: Future Directions and Collaborative Efforts - The integration of various purification techniques is essential for comprehensive toxin removal, which is crucial for improving patient outcomes [11]. - Continuous collaboration among medical institutions, enterprises, and social organizations is necessary to support uremic patients in achieving a better quality of life [13].

Core Viewpoint - The recent refund announcement by Menglian County People's Hospital in Yunnan highlights the increasing scrutiny of medical institutions regarding the misuse of medical insurance funds, revealing both the hospital's proactive approach to rectify past mistakes and the underlying issues within its governance structure [2][3][4]. Group 1: Refund Announcement - Menglian County People's Hospital has initiated a refund process for patients, with amounts ranging from 0.03 yuan to 67.18 yuan, following a self-examination of its billing practices [1]. - The hospital's actions are rare in the healthcare sector, drawing significant public attention and raising questions about the integrity of medical billing practices [1]. Group 2: Background of the Incident - The refund stems from a report by the Pu'er City Medical Insurance Bureau, which identified various violations by the hospital, including excessive testing and duplicate charges, leading to a total loss of 27,883.46 yuan in medical insurance funds [2]. - The hospital has reportedly returned all misused funds and paid fines as mandated by the authorities [2]. Group 3: Regulatory Environment - The national government has intensified oversight of medical insurance fund usage, employing advanced technologies such as big data analysis and real-time monitoring to detect previously hidden violations [3]. - The proactive refund by the hospital can be seen as a response to this regulatory trend, aimed at reducing potential penalties [3]. Group 4: Governance Issues - The incident underscores significant governance failures within the hospital, as evidenced by the involvement of its leadership in serious misconduct [3]. - The hospital's focus on profit over patient care has led to a range of unethical practices, including overcharging and unnecessary medical procedures [3]. Group 5: Recommendations for Improvement - To prevent future issues, it is essential for medical institutions to establish transparent billing practices and enhance internal auditing and compliance mechanisms [4]. - The ongoing development of intelligent medical insurance supervision systems is crucial for monitoring medical practices and preventing violations [4].

Core Points - The Sichuan Provincial Medical Insurance Bureau announced the successful investigation of a major medical insurance fraud case involving five medical institutions, including Chengdu Jiuxing Kidney Hospital and Chengdu Gaoxin Bolin Hospital, with a total fraud amount of 48.08 million yuan [1] - The investigation led to the termination of medical insurance agreements with the involved institutions, the detention of 35 individuals, and the approval of arrests for 16 individuals [1][4] - Longsheng Medical, a well-known national dialysis chain, operates over 100 hospitals and centers across 15 provinces, providing services to more than 17,000 dialysis patients [2] Medical Institutions Involved - Chengdu Jiuxing Kidney Hospital and Chengdu Gaoxin Bolin Hospital are part of Longsheng Medical, which has been implicated in fraudulent activities such as selling "return flow drugs" and offering free dialysis [1][2] - Following the fraud investigation, Chengdu Jiuxing Kidney Hospital has reportedly ceased operations, while Chengdu Gaoxin Bolin Hospital has been rebranded as Chengdu Gao Xin South Hospital, which is currently operational [4][5] Regulatory Actions - The National Medical Insurance Administration has issued a notice to address fraudulent practices in the dialysis sector, emphasizing the need for medical institutions to charge based on actual services provided and prohibiting misleading practices such as "free treatment" [3] - The Sichuan Provincial Medical Insurance Bureau has recovered 4.89 million yuan in principal and penalties from the involved institutions and has suspended payments totaling 70.41 million yuan [4]